College of Law > About > Events & CLE > Featured Events > Health Law Symposium > Past Symposia
Access issues in health care are beginning to reach crisis point. Over the past decade, corporate interests have dictated structural changes in health care markets and consumers now face more barriers than ever when it comes to obtaining affordable, quality care. In response, the Biden Administration and the newly formed White House Competition Counsel are promoting more vigorous antitrust enforcement—scrutinizing actions taken by hospitals and drug companies in particular. This year’s symposium will explore how consolidation across health care markets has impacted access to care. Prominent legal scholars, antitrust enforcers, and expert practitioners will address a range of questions:
DePaul College of Law is an accredited MCLE provider, and this event is eligible for up to 7 CLE credit hours.
There are few spaces where rapid changes in technology impact our lives as profoundly as in the realm of healthcare. While advances in healthcare technologies signal immense progress for medicine and science, they also raise significant questions related to who has access to these innovations, and whether the advances are making us healthier as a whole.
COVID-19 has laid bare the structural barriers at the root of health disparities in the U.S. This year’s Jaharis Symposium centers on the premise that while technological advances have the potential to revolutionize the delivery of health care, they also raise significant questions about who has access to these innovations and whether they are advancing the interests of the populations with the greatest needs.
DePaul College of Law is an approve MCLE provider. This event is worth up to 5.75 general CLE hours.
Co-sponsored by the Mary and Michael Jaharis Health Law Institute and the Center for Intellectual Property Law & Information Technology (CIPLIT®).
Recent discoveries in the field of genetics herald immense innovation for medicine and science. However, they also raise significant questions related to individual privacy, societal uses of the information, and applications in the criminal justice system. For example, how should genetic information be controlled to ensure individual privacy and informed consent for all? What are the individual and societal implications of forensic uses of genetic record matching? How else should genetic information be used within the criminal justice system? Can genomic research ever be truly inclusive and representative of the diversity of our population
This 2020 interdisciplinary symposium addresses issues of distributive and procedural justice in genetics and genomics, as they relate to scientific innovation, intellectual property, human subjects research, and the criminal justice system.
“Democratizing” Medicine in a Data and Tech-Driven World.March 14, 2019
Technological and Emergency Responses to Pandemic Diseases
Telehealth: Transforming the Healthcare Delivery Landscape
The New Frontier of Health Innovation: Navigating the Regulatory Landscape
Designer Genes: The Cost of Genetic Information